Study of Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of NIO752 in Early Alzheimer's Disease Participants
Clinical trial NCT05469360 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05469360
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-23
- Primary completion
- 2026-07-30
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.